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Abstract
DNA methylation is a prevalent epigenetic modification involved in
transcriptional regulation and essential for mammalian develop-
ment. While the genome-wide distribution of this mark has been
studied to great detail, the mechanisms responsible for its correct
deposition, as well as the cause for its aberrant localization in
cancers, have not been fully elucidated. Here, we have compared
the activity of individual DNMT3A isoforms in mouse embryonic
stem and neuronal progenitor cells and report that these isoforms
differ in their genomic binding and DNA methylation activity at
regulatory sites. We identify that the longer isoform DNMT3A1
preferentially localizes to the methylated shores of bivalent CpG
island promoters in a tissue-specific manner. The isoform-specific
targeting of DNMT3A1 coincides with elevated hydroxymethylcy-
tosine (5-hmC) deposition, suggesting an involvement of this
isoform in mediating turnover of DNA methylation at these sites.
Through genetic deletion and rescue experiments, we demonstrate
that this isoform-specific recruitment plays a role in de novo DNA
methylation at CpG island shores, with potential implications on
H3K27me3-mediated regulation of developmental genes.
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Introduction
DNA methylation is a well-established epigenetic mark involved in
gene regulation and genome stability. The importance of DNA
methylation for mammalian genome function is apparent by the
lethal phenotypes observed upon individual and combined knock-
out of DNA methyltransferases, whereas DNMT1 and DNMT3B
knock-outs are embryonic lethal and DNMT3A knock-outs are lethal
4 weeks after birth (Lei et al, 1996; Okano et al, 1999; Chen et al,
2003). Furthermore, aberrant deposition of DNA methylation is
frequently observed in cancers (Baylin, 2005; Yan et al, 2011).
Recent genome-wide initiatives explored the distribution of methy-
lated CpGs in various cell types and tissues at single-base pair reso-
lution (Lister et al, 2009; Stadler et al, 2011; Hon et al, 2013). These
datasets were crucial in identifying the frequency and localization of
methylated cytosines, and also to monitor changes in methylation
during cellular transitions, including differentiation in healthy indi-
viduals (Schultz et al, 2015) or cellular transformation (Akalin et al,
2012; Hovestadt et al, 2014). Furthermore, the discovery of 5-hydro-
xymethylcytosine (5-hmC) as an additional modification of mamma-
lian genomes and the characterization of TET-mediated DNA
methylation removal (Kriaucionis & Heintz, 2009; Tahiliani et al,
2009; Kohli & Zhang, 2013) provide compelling evidence that DNA
methylation is highly dynamic and undergoes constant turnover at
regulatory sites (Stroud et al, 2011; Feldmann et al, 2013; Kohli &
Zhang, 2013).
The de novo enzymes DNMT3A and DNMT3B are responsible for
establishing DNA methylation, while DNMT1 is the maintenance
methyltransferase responsible for propagation of this mark at CpG
dinucleotides after DNA replication. In addition, the de novo DNMTs
are responsible for the frequently occurring non-CpG methylation in
mammalian genomes and contribute to maintenance of CpG methy-
lation through filling up gaps after DNMT1 or counteracting active
demethylation (Ramsahoye et al, 2000; Liang et al, 2002; Jackson
et al, 2004; Arand et al, 2012). Recently, DNMT3C, a novel rodent-
specific member of the de novo DNMT family, has been identified to
regulate DNA methylation in the male germline (Barau et al, 2016).
How DNMTs are correctly recruited to the genome in order to estab-
lish and maintain DNA methylation is not completely understood. In
addition, splicing and alternative promoter usage gives rise to vari-
ous catalytically active and inactive DNMT isoforms with tissue- and
cancer-specific expression preferences (Chen et al, 2002; La Salle &
Trasler, 2006; Gopalakrishnan et al, 2009; Duymich et al, 2016),
revealing a complex regulation of DNA methylation through isoform
variation. Previous studies have measured subcellular localization,
catalytic activity, and targeting specificities of these isoforms in
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various cell types and in vitro (Chen et al, 2002, 2003; Choi et al,
2011; Gordon et al, 2013; Duymich et al, 2016). However, the
in vivo preferences of individual isoforms and their contribution to
the DNA methylation landscape remains to be uncovered.
Based on numerous biochemical, structural, and genome-wide
studies, the context-dependent crosstalk of DNA methylation with
histone modifications, DNA sequence properties, transcriptional
activity, or transcription factors became more and more apparent
in the recent years (Rose & Klose, 2014; Ambrosi et al, 2017).
Most importantly, histone modifications have been identified to
play a major role in guiding DNA methylation (Rose & Klose,
2014; Du et al, 2015). For example, H3K4me3 prevents binding
of the de novo methyltransferases to unmethylated CpG islands
(Otani et al, 2009) and H3K36me3 was identified to enhance
DNMT3B localization to actively transcribed gene bodies in vivo
(Baubec et al, 2015). At the same time, DNA methylation has
been shown to influence the deposition of histone modifications.
For example, removal of DNA methylation results in spreading of
the H3K27me3 mark from bivalent promoters (Lynch et al, 2011;
Brinkman et al, 2012; Marks et al, 2012; Reddington et al, 2013;
Jermann et al, 2014), and switching between H3K27me3- and
DNA methylation-mediated repression has been described during
development and in cancer (Schlesinger et al, 2006; Widschwendter
et al, 2006; Mohn et al, 2008). This antagonism between DNA
methylation and H3K27me3 suggests a dynamic crosstalk between
these epigenetic marks that could be required for ensuring correct
gene expression programs.
In this study, we explored the role of DNMT3A in establishing
DNA methylation patterns in mouse ES and neuronal progenitor
cells. More specifically, we focused our attention on the genomic
location and DNA methylation activity of the longer DNMT3A
isoform, DNMT3A1 (Fig 1A). We show that DNMT3A1 preferen-
tially localizes to CpG islands bivalently marked by H3K4me3 and
H3K27me3 in mouse embryonic stem cells, coinciding with the
promoters of many transcription factors. This preference is further
observed during neuronal differentiation, where DNMT3A1 binding
follows H3K27me3 dynamics. DNMT3A1 binding to these sites coin-
cides with elevated 5-hmC deposition at CpG island shores, and loss
of DNMT3A results in reduced 5-hmC and erosion of DNA methyla-
tion at these sites. Re-expression of DNMT3A1, but not DNMT3A2,
in Dnmt-triple-KO ES cells preferentially re-targets DNA methylation
to bivalent CpG island shores and results in increased production of
5-hmC. These results demonstrate that the DNMT3A1 isoform is
responsible for sustaining methylcytosine turnover at bivalent CpG
islands.
Results
Isoform-specific localization of DNMT3A1 and DNMT3A2 to the
genome of mouse ES cells
The Dnmt3a gene is transcribed from two alternative promoters,
resulting in two protein isoforms: DNMT3A1 and DNMT3A2, respec-
tively (Chen et al, 2002) (Fig 1A and Appendix Fig S1A). We have
analyzed the differential expression of these two isoforms in detail
during in vitro differentiation of murine ES cells (Appendix Fig S1B
and C) and by using publicly available CAGE-seq data obtained from
various stages and tissues during mouse development (FANTOM5
Consortium, 2014). The CAGE-seq analysis indicates that the shorter
isoform DNMT3A2 is mainly expressed during early development,
whereas the longer DNMT3A1 isoform is expressed in the majority
of samples (Fig 1B, Appendix Fig S1D and E, and Dataset EV1).
Given these differences in isoform expression, we wanted to investi-
gate the binding behavior of the DNMT3A isoforms and their
potential contribution to DNA methylation. Standard chromatin
immunoprecipitation (ChIP) for DNMT proteins is limited by the
availability of suitable antibodies and furthermore does not allow
to distinguish genomic binding preferences between protein
isoforms. To overcome these limitations, we have utilized
RAMBiO (Baubec et al, 2013), a biotin-tagging approach which we
have previously employed to investigate genomic binding of
DNMTs in mouse ES cells (Baubec et al, 2015). This approach
allowed us to tag individual DNMT3A isoforms, express them
from the same heterologous genomic site at similar levels, and
perform stringent detection of DNMT3A binding by streptavidin-
based ChIP followed by high-throughput sequencing (Appendix
Fig S2A–E and Dataset EV2).
Using this approach, we have obtained binding maps for
DNMT3A1 in mouse ES cells from two individual clones, and
compared its binding to DNMT3A2 and DNMT3B1 (Fig 1C–F and
Appendix Fig S3A and B). Similar to DNMT3A2 and DNMT3B, bind-
ing of DNMT3A1 is excluded from unmethylated and low methy-
lated regions (LMR) that coincide with active proximal and distal
regulatory elements (UMR and LMR, respectively, from Stadler et al,
2011), while fully methylated regions (FMR) are bound by
DNMT3A1 in a methylation density-dependent manner (Fig 1C and
Appendix Fig S3C and D). However, we observed several differences
in DNMT3A1 binding when compared to the other DNMT3 proteins,
suggesting that this isoform could display unique targeting prefer-
ences to the genome. This is evident from lack of binding to actively
transcribed gene bodies occupied by DNMT3B (Baubec et al, 2015)
(Fig 1D), differential localization at numerous sites in the genome
(Fig 1E and Appendix Fig S3E), and from its genome-wide correla-
tions to various chromatin features. The latter indicates preferential
localization of DNMT3A1 to genomic sites enriched for H3K27me3
(Fig 1F and Appendix Fig S3F)—a feature not observed for
DNMT3A2 or DNMT3B. This differential binding behavior of
DNMT3A1 motivated us to explore the localization of this isoform
in more detail.
The DNMT3A1 isoform localizes to H3K27me3-positive CpG
island shores
Based on the observed differences in genomic binding between the
DNMT3A isoforms and DNMT3B, we aimed to identify individual
and overlapping binding sites of these enzymes. Therefore, we have
calculated statistically significant enriched regions for each individ-
ual DNMT protein (see Materials and Methods), resulting in 3,970
regions exclusively enriched for DNMT3A1, 3,838 for DNMT3A2,
3,432 for DNMT3B, and sites that are shared between the de novo
DNMT proteins (Fig EV1A and Appendix Fig S4A). In order to
extract the binding preferences of DNMT3A1, we have focused our
attention on the exclusively bound regions only and characterized
these by calculating enrichments for various chromatin modifi-
cations, transcription, and local sequence properties. We again
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observed that DNMT3A1-bound sites are frequently enriched for
H3K27me3, while DNMT3A2 sites do not display any preference,
and DNMT3B sites are associated with transcribed regions marked
by H3K36me3 as previously described (Baubec et al, 2015) (Fig 2A
and B, and Appendix Fig S4A). Direct comparison between the
antagonistic modifications H3K27me3 and H3K36me3 on a genome-
wide scale further revealed the isoform-specific preference of
DNMT3A1 for H3K27me3-bound sites (Fig 2C). Surprisingly,
although DNA methylation levels measured directly at DNMT-
binding sites are comparably high for all three proteins (> 80%
average, Fig 2D and Appendix Fig S4B), regions immediately
upstream and downstream of the DNMT3A1-binding sites display a
sharp reduction in DNA methylation (Fig 2D, top). CpG density
analysis revealed the opposite behavior, with increasing CpG
density immediately upstream and downstream of DNMT3A1-
binding sites (Fig 2D, bottom). This was not evident for DNMT3A2-
or DNMT3B-bound sites, suggesting that genomic regions with
reduced DNA methylation and increased CpG density frequently
occur near DNMT3A1-binding sites (Fig EV1B).
These results indicate a potential preference of the longer isoform
DNMT3A1 for hypomethylated and CpG-rich regulatory regions
decorated by H3K27me3. Therefore, we have focused our attention
on the CpG island promoters that are bivalent for H3K4me3 and
H3K27me3 marks (Mikkelsen et al, 2007; Mohn et al, 2008). By
binning CpG island promoters into bivalent and non-bivalent
promoters based on the presence of H3K27me3 (Appendix Fig S4C),
we could observe that DNMT3A1 is mainly enriched at bivalent
CpG islands (Figs 2E and EV1C). However, DNMT3A1 does not
completely overlap with the H3K27me3 signal and is excluded from
the center of the CpG island—in line with H3K4me3 preventing
binding of de novo DNMTs through their ADD domains (Otani et al,
2009). Instead, DNMT3A1 localizes upstream and downstream of
the CpG islands (Fig 2E and Appendix Fig S4D), coinciding with
CpG island shores that have been reported to be differentially
A
D E F
B C
Figure 1. The DNMT3A isoforms DNMT3A1 and DNMT3A2 display differential localization along the mouse ES cell genome.
A Similarities in domain composition and amino acid sequence between murine DNMT3A and DNMT3B. Conserved amino acids are indicated as red bars. The longer
and shorter DNMT3A isoforms DNMT3A1 and DNMT3A2 are shown.
B Differential expression of DNMT3A isoforms measured by CAGE-seq data obtained from the FANTOM5 consortium. Indicated are data points obtained from various
tissues during early mouse development at the indicated embryonic days (E) and from adult animals. Shown are log2-transformed CAGE-seq read counts overlapping
the isoform-specific promoters (see also Appendix Fig S1D and E).
C Average profiles indicating DNMT3A1 binding around genomic regions containing unmethylated, low methylated, and fully methylated regions (UMR, LMR, and FMR,
respectively, from Stadler et al, 2011). DNA methylation at these sites is indicated in gray (% m-CpG); binding of DNMT3A1 is indicated in red (average read counts
from ChIP-seq data). At FMRs, DNMT3A1 binding is shown at three FMR groups stratified by methyl-CpG-density to indicate binding dependency on the density of
methylated CpGs (see also Appendix Fig S3C and D).
D Comparative binding analysis between DNMT3A1, DNMT3A2, and DNMT3B indicates lack of DNMT3A recruitment to transcribed gene bodies. Shown are average
density plots for ChIP-seq read counts around non-overlapping genes scaled by gene length.
E Representative genome browser view exemplifying differences in binding between the de novo methyltransferases. Shown are read counts per 100 bp for ChIP-seq
and input samples. Gene models, CpG islands, and repetitive elements from the UCSC genome browser are indicated below. Top track indicates differential binding
between DNMT3A1 (red) and DNMT3A2 (orange).
F Genome-wide cross-correlation analysis between de novo DNMT binding and various chromatin modifications. Pearson’s correlations are calculated on log2-
transformed read counts over 1-kb-sized tiles covering the mouse genome. Increased correlations between DNMT3A1 and H3K27me3, as well as for DNMT3B with
transcriptionally active features, are indicated by red and blue boxes, respectively.
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methylated during development and in cancer (Doi et al, 2009;
Irizarry et al, 2009; Hodges et al, 2011). This specific localization is
not observed for DNMT3B which is fully absent from CpG islands
shores, and only to a minor degree for DNMT3A2 (Fig 2E and
Appendix Fig S4D), indicating an isoform-dependent recruitment of
DNMT3A to these sites. We furthermore characterized the Gene
Ontology annotation of the genes neighboring DNMT3A1-bound
sites using GREAT (McLean et al, 2010) in order to identify whether
there is a preference for a specific set of genes. This analysis
revealed that DNMT3A1 sites coincide with genes involved in tran-
scriptional regulation, including numerous DNA sequence-specific
transcription factors (Fig EV1D). This enrichment was evident only
for DNMT3A1 sites, further supporting the specific association of
this isoform with Polycomb-regulated promoters of genes involved
in developmental and differentiation processes.
DNMT3A1 coincides with H3K27me3 in a cell
type-specific manner
In order to test whether DNMT3A1 binding to Polycomb CpG island
shores is cell type specific, we followed the genome-wide binding of
both DNMT3A isoforms during differentiation of ES cells expressing
the biotin-tagged isoforms to homogenous populations of neuronal
progenitors (NPs) (Appendix Fig S2B and C). We first contrasted
DNMT3A isoform binding dynamics to changes in DNA methylation
to identify their potential contribution to the reported de novo
methylation of proximal and distal regulatory regions during
neuronal differentiation (Mohn et al, 2008; Stadler et al, 2011).
Therefore, we have identified genomic regions that gain DNA
methylation in neuronal progenitors based on available whole-
genome bisulfite sequencing data obtained from the same cellular
system (Stadler et al, 2011) (Appendix Fig S5A and B), and visual-
ized cell type-specific DNMT3A protein binding to these regions.
Both DNMT3A isoforms show increased recruitment to de novo
methylated sites in neuronal progenitors (Fig 3A and Appendix Fig
S5C), suggesting that both isoforms are involved in establishment of
DNA methylation during early differentiation.
H3K27me3 is differentially localized to the genome in a cell type-
specific manner (Mikkelsen et al, 2007; Mohn et al, 2008), and we
observed that binding of DNMT3A isoforms differs at sites positive
for H3K27me3 in neuronal progenitors. DNMT3A1, but not
DNMT3A2, follows H3K27me3 dynamics and preferentially relo-
cates to the vicinity of H3K27me3 during differentiation (Fig 3B and
C, and Appendix Fig S5D–G). This isoform-specific recruitment was
observed at sites gaining H3K27me3 and at genomic regions that
have lost H3K27me3 in neuronal progenitors, including Hox gene
clusters (Appendix Fig S5F). In addition, sites that display cell type-
specific binding of DNMT3A1 in conjunction with H3K27me3
dynamics are also frequently accompanied by changes in DNA
methylation (Fig 3C and Appendix Fig S5F).
Differential recruitment of DNMT3A1 is mediated by its variant
N-terminal region
We next wanted to explore how the genomic binding preference of
DNMT3A1 is mediated toward H3K27me3 sites. First, we asked
whether differential binding is caused by protein–protein interac-
tions that are specific only to one of the two isoforms. We therefore
A
C
D E
B
Figure 2. The DNMT3A1 isoform preferentially localizes to H3K27me3-
bivalent CpG islands.
A Enrichment analysis of chromatin features under DNMT3-protein-binding
sites reveals increased H3K27me3 localization at sites bound by DNMT3A1.
Shown are average log2-enrichments of the indicated chromatin
modifications and factors over input at sites exclusively bound by
individual de novo DNMTs.
B Box plots indicating log2-enrichment over input for H3K27me3 and
H3K36me3 at DNMT3A1-, DNMT3A2-, and DNMT3B-binding sites, and
compared to average enrichment in the entire genome. Boxes denote the
inter-quartile range (IQR) and whiskers 1.5 × IQR.
C Scatter plots indicating the specific binding preference of DNMT3A1 for
H3K27me3 and DNMT3B for H3K36me3. Shown are genome-wide
enrichments over input for these histone modifications highlighting their
mutual exclusiveness (gray) and the location of DNMT3A1 (red)-, DNMT3A2
(orange)-, and DNMT3B (blue)-bound sites along these genomic
distributions.
D DNA methylation levels and CpG densities differ around de novo DNMT-
binding sites. Top: Shown are average methylation values for CpGs
centered around DNMT-binding sites (gray area). Bottom: Shown are CpG
densities calculated as number of CpG dinucleotides per 100 bp at DNMT3-
binding sites. Average densities are calculated for exclusive binding sites of
DNMT3A1 (red), DNMT3A2 (orange), and DNMT3B (blue).
E DNMT3A1 preferentially localizes upstream and downstream of bivalent
CpG island promoters. Shown are heat map density profiles for DNMT3
protein binding and chromatin features around all promoter-associated
CpG islands and CpG promoters separated by H3K27me3. CpG island
promoters are oriented according to their downstream gene.
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performed co-immunoprecipitation experiments from nuclear
extracts in embryonic stem cells expressing the biotinylated
DNMT3A isoforms as baits. Mass spectrometric detection of
enriched proteins identified already-reported protein interactions of
DNMT3A, including DNMT3L (Hata et al, 2002), DNMT3B (Li et al,
2007), EHMT1, and EHMT2 (Chang et al, 2011) (Fig 4A and B, and
Dataset EV3). However, this analysis did not reveal any drastic dif-
ferences in protein–protein interactions between the two DNMT3A
isoforms. While the PRC2 components EZH2, SUZ12, and EED could
be detected in the enriched fraction (Fig 4A and B), these were simi-
lar for both isoforms, suggesting that isoform-specific DNMT3A
interactions with PRC2 members do not contribute to the observed
genome-wide binding preference.
Based on the previous reports, the variant N-terminal regions of
DNMT3A and DNMT3B are involved in mediating chromatin and
DNA interactions (Jeong et al, 2009; Suetake et al, 2011; Baubec
et al, 2015), we wanted to investigate the requirement of this
N-terminal region for the observed localization of DNMT3A1 to
H3K27me3 sites. We therefore have generated ES cell lines
expressing a chimeric version of DNMT3A1 where we have replaced
the N-terminal part with that from DNMT3B (N3B-DNMT3A,
Appendix Fig S6A). Using this cell line, we have repeated the
genome-wide binding experiments in ES cells and measured the
localization of the chimeric N3B-DNMT3A protein to CpG island
promoters decorated by H3K27me3 and to genomic sites preferen-
tially bound by the wild-type DNMT3 proteins. We observed that
replacing the N-terminal part of DNMT3A1 reduces its preference
for H3K27me3-positive CpG island promoters and for DNMT3A1-
bound sites (Fig 4C and D, and Appendix Fig S6B and C). This
indicates that the N-terminal part is required for the observed
genome-wide binding preference of DNMT3A1 to Polycomb-regu-
lated CpG islands. However, addition of the DNMT3B N-terminal
end to DNMT3A did not result in increased localization of the
chimeric N3B-DNMT3A protein to gene bodies (Appendix Fig S6D).
DNMT3A1 regulates DNA methylation at bivalent CpG islands
Previous studies have already highlighted that CpG island shores are
differentially methylated in various cell types and cancers (Irizarry
et al, 2009; Hodges et al, 2011). Therefore, the dynamic recruitment
of DNMT3A1 to the vicinity of Polycomb-associated CpG islands
A B
C
Figure 3. Dynamic colocalization of DNMT3A1 with H3K27me3 during
neuronal differentiation.
A Both DNMT3A isoforms dynamically localize to de novo methylated regions
during neuronal development. Increased DNMT3A binding in neuronal
progenitors (NP) is shown as log2-fold difference between ES and NP cells
(y-axis) and is ranked based on de novo DNA methylation in NPs (x-axis).
Individual data points denote median log2-fold changes calculated from
500 consecutive windows ranked by DNA methylation.
B Scatter plots indicate that genome-wide dynamics in DNMT3A1 binding
correlates with regions that change H3K27me3 during neuronal
differentiation. Shown are log2-fold changes between ES and NP ChIP-seq
signals of DNMT3A isoforms and H3K27me3 calculated at 1-kb windows
positive for H3K27me3 in ES and/or NP cells.
C Genome browser examples for regions that change DNMT3A1 binding and
DNA methylation according to H3K27me3. Shown are read counts per
100 bp for ChIP-seq datasets and percentage of DNA methylation per
individual CpGs. Regions that show concomitant changes in DNMT3A1 and
DNA methylation are highlighted in gray.
A
C
D
B
Figure 4. The N-terminal part of DNMT3A1 is required for localization to
H3K27me3 sites.
A Scatter plot indicating similarities in protein–protein interactions between
DNMT3A1 and DNMT3A2. Shown are the unique spectral counts per protein
obtained from co-immunoprecipitation experiments performed in cell lines
expressing biotin-tagged DNMT3A1 or DNMT3A2. The Pearson’s correlation
coefficient is shown. Red dots indicate proteins listed in (B).
B Table indicating top-scoring proteins identified to interact with DNMT3A1
or DNMT3A2 in mouse ES cells. Shown are the results from (A) and an
untagged cell line (empty) that serves as background control.
C Genome browser example for regions indicating reduced binding of the
chimeric N3B-DNMT3A protein to H3K27me3 sites. Shown are read counts
per 100 bp for ChIP-seq datasets and percentage of DNA methylation per
individual CpGs.
D Average density plot around H3K27me3-positive and H3K27me3-negative
CpG island promoters indicates reduced binding of the chimeric N3B-
DNMT3A protein to H3K27me3 sites (see Appendix Fig S6B).
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suggests a role for this isoform to demarcate the correct transition
between methylated and unmethylated DNA at CpG island
borders. We have utilized whole-genome bisulfite sequencing data
from mouse ES cells (Stadler et al, 2011) to precisely map the
transition from fully methylated (FMR) to unmethylated regions
(UMR) around CpG island promoters (Appendix Fig S7A–C). This
allowed us to better visualize DNMT3A1 localization to
H3K27me3-positive UMRs and compare it to various other chro-
matin features at these sites (Appendix Fig S7D–F). This analysis
revealed that 5-hmC is predominantly enriched at borders of
H3K27me3-positive UMRs that are co-occupied by DNMT3A1
(Fig 5A and B, and Appendix Fig S7E). Clustering analysis of
UMRs based on DNMT3A1 binding further reveals co-occurrence
of DNMT3A1 with H3K27me3 and Polycomb group proteins at
transcriptionally inactive genes, as well as site-specific colocaliza-
tion with 5-hmC (Figs 5C and EV2A–D). TET1, the protein
involved in oxidation of methylcytosine, is ubiquitously localized
at all UMRs (Fig 5A and B).
The increased abundance of 5-hmC at Polycomb-regulated CpG
islands coincides with preferential recruitment of DNMT3A1 to CpG
island shores and suggests an involvement of DNMT3A1 in de novo
DNA methylation at these sites. In order to directly test the require-
ment of DNMT3A, we have knocked out the Dnmt3a gene by using
CRISPR/Cas9 (Appendix Fig S8A) and measured 5-hmC levels in
these cell lines. This revealed a strong reduction in the 5-hmC signal
at the borders of bivalent UMRs in the absence of DNMT3A (Fig 5D
and Appendix Fig S8B and C), indicating that DNMT3A generates
the substrate for TET-mediated oxidation at CpG island shores. To
follow up on this potential role, we have measured DNA methyla-
tion at these sites using reduced-representation bisulfite sequencing
(RRBS) in wild-type and Dnmt3a KO ES cells. Analysis of DNA
methylation at the UMR flanks reveals that absence of DNMT3A
leads to a reduction in DNA methylation at H3K27me3-positive
UMRs (Fig 5E and Appendix Fig S8D and E).
However, these experiments were performed in a cell line where
both DNMT3A isoforms have been deleted (Appendix Fig S8A).
A B
C D E
Figure 5. Binding of DNMT3A1 to CpG island shores is required for DNA methylation regulation and promotes 5-hmC deposition.
A Heat map profiles of DNMT protein binding and chromatin features around promoter-associated unmethylated regions (UMR) oriented by gene direction and ranked
by H3K27me3 show a preferential association of DNMT3A1 with H3K27me3-decorated UMRs. Furthermore, H3K27me3-positive UMRs are enriched for 5-hmC signals
flanking the unmethylated center.
B Average density profiles for top 25% of UMRs ranked by H3K27me3 indicate a localized 5-hmC signal at borders of UMRs that is localized between DNMT3A1- and
TET1-binding sites (top). Top 25% of UMRs ranked by H3K27ac lack DNMT3A1 enrichment and have a more uniform 5-hmC signal (bottom). Shown are library-
normalized read counts.
C Average density profiles for UMR regions clustered based on DNMT3A1 binding. Five clusters were defined by k-means clustering that show distinct DNMT3A1
binding (d 1–5, see also Fig EV2 for more details). Clusters with highest DNMT3A1 binding are also enriched for H3K27me3 and also display elevated 5-hmC signals at
UMR borders.
D Average density plots centered over UMR borders identify a sharp signal in 5-hmC at the transition from FMR to UMR states in wild-type cells. This signal is reduced
in ES cells lacking DNMT3A and is absent in the Dnmt-TKO cell line.
E DNA methylation is reduced around bivalent CpG islands in DNMT3A-KO ES cells. Shown is the average DNA methylation measured by RRBS around UMR borders.
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Consequently, it did not allow us to directly address isoform-specific
DNA methylation, and furthermore, we cannot exclude that the
remaining DNMT3B and DNMT1 proteins could partially compen-
sate for the loss of DNMT3A at these sites. To directly test whether
DNMT3A1 is indeed the main isoform responsible for setting DNA
methylation at these sites, we have introduced DNMT3A1 into
Dnmt-TKO cell lines that lack DNA methylation and 5-hmC, and
performed whole-genome bisulfite sequencing (Appendix Fig S9A
and B). In this situation, de novo methylation is only guided by
DNMT3A1 binding preference, and in the absence of maintenance
activity, DNA methylation should be only detected at sites preferen-
tially targeted by DNMT3A1. Indeed, we observe that DNMT3A1-
enriched regions are preferentially methylated compared to sites
bound by DNMT3A2 or DNMT3B (Fig 6A), supporting that de novo
methylation by DNMT3A1 is largely regulated by its targeting pref-
erence. Despite the increased methylation at sites directly bound by
DNMT3A1, we again noticed that the methylation signal is reduced
upstream and downstream of the DNMT3A1-binding sites due to the
presence of neighboring CpG islands (Fig 6A), reminiscent of our
observations obtained in wild-type cells (Fig 2D). Since DNMT3A1
is enriched at bivalent CpG island shores, we have directly analyzed
the de novo DNA methylation rate at these sites. Density profiles
surrounding H3K27me3-positive UMRs revealed an increased prefer-
ence of de novo methylation in TKO cells expressing DNMT3A1
(Fig 6B and Appendix Fig S9C–E). This preference was not observed
upon expression of the shorter DNMT3A2 variant in the Dnmt-TKO
background (Fig 6B and Appendix Fig S9C–E), indicating that
DNMT3A1 is the main isoform involved in regulating DNA methyla-
tion at bivalent CpG islands.
DNMT3A1 recruitment promotes increased m-CpG turnover
around H3K27me3 sites
To test whether the DNMT3A isoform-specific de novo methylation
of cytosines is further oxidized by the TET enzymes, we have
measured 5-hmC in the TKO cells expressing individual DNMT3A
isoforms. These experiments revealed that re-expression of
DNMT3A1, but not DNMT3A2, leads to an increased 5-hmC produc-
tion around bivalent CpG islands (Fig 6C and D, and Appendix Fig
S9F), demonstrating that the enzymatic activity of the DNMT3A1
isoform is providing the substrate for TET-mediated oxidation of
methylated cytosines at these sites. 5-hmC is further processed by
the TET enzymes to 5-formyl- and 5-carboxyl-methylcytosine (5-fC
and 5-caC, respectively)—intermediates that are rapidly removed by
the DNA repair enzyme TDG (Ito et al, 2011; He et al, 2011). Previ-
ous studies have indicated an accumulation of 5-fC and 5-caC at
enhancers and H3K27me3-decorated promoters after knock-out or
knock-down of TDG, revealing that DNA methylation turnover is
actively occurring at these regulatory elements (Shen et al, 2013;
Song et al, 2013). By re-analyzing these datasets, we observed an
increase in 5-fC and 5-caC signals at DNMT3A1-enriched sites in the
absence of TDG (Appendix Fig S10A and B), further supporting that
binding of DNMT3A1 primarily occurs at sites with elevated turn-
over of cytosine methylation.
We have further investigated whether isoform-specific contribu-
tion of DNMT3A to DNA methylation turnover also occurs outside
of Polycomb CpG island promoters. Toward this, we calculated the
genome-wide differences in de novo DNA methylation activity and
A
C D
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Figure 6. De novo DNA methylation activity of DNMT3A1 is directed to
bivalent CpG island shores.
A Analysis of de novo DNA methylation in Dnmt-TKO cells re-expressing
DNMT3A1 shows preferential DNA methylation activity at DNMT3A1-
binding sites. Exclusive binding sites from DNMT3A1, DNMT3A2, and
DNMT3B are shown in red, orange, and blue, respectively.
B Expression of DNMT3A1, but not DNMT3A2, in Dnmt-TKO cells results in
preferential de novo DNA methylation around bivalent CpG islands.
Density plots show average methyl-CpG percent calculated from WGBS
data around UMRs binned based on H3K27me3 or H3K27ac enrichment
(top 25% ranked UMRs).
C, D Re-expression of DNMT3A1 but not DNMT3A2 results in 5-hmC
accumulation at bivalent CpG island shores. (C) Average density plots
indicating 5-hmC read counts at UMR borders separated by H3K27me3
or H3K27ac from two independent replicates. (D) Representative genome
browser views.
E Percentage of genes with significant increase in gene expression in
Dnmt-TKO over wild-type cells (FDR < 0.001 & log2-FC > 0.5) according
to their promoter classification. Promoters with more than 80% DNA
methylation in wild-type cells (black); promoters with < 20% DNA
methylation in wild-type cells (gray); or unmethylated CpG island
promoters falling into one of five clusters based on DNMT3A1 binding
(see Figs 5C and EV2A). P-values calculated based on hypergeometric
tests are shown only for fractions with P-value < 0.05.
F DNMT3A1 is preferentially recruited to the shores of bivalent CpG islands
to maintain DNA methylation in the presence of TET-mediated oxidation
of methyl-cytosines to 5-hmC.
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5-hmC accumulation between TKO cells expressing DNMT3A1 or
DNMT3A2, and compared these with chromatin features
(Appendix Fig S10C). In general, we did not observe additional
isoform-specific preferences toward other genomic features besides
H3K27me3-decorated sites. In addition, enhancers that have been
reported to display elevated DNA methylation turnover (Stroud
et al, 2011; Feldmann et al, 2013) do not show any isoform-specific
differences in de novo DNA methylation or 5-hmC accumulation
(Appendix Fig S10D).
The site-specific recruitment of DNMT3A1 to Polycomb CpG
island shores could have implications for H3K27me3 deposition at
CpG island promoters. In the absence of DNA methylation,
H3K27me3 has been reported to spread into neighboring regions,
resulting in depletion of H3K27me3 from CpG island centers and
influencing activity of Polycomb-regulated genes (Fouse et al, 2008;
Lynch et al, 2011; Brinkman et al, 2012; Marks et al, 2012; Redding-
ton et al, 2013; King et al, 2016). By reinvestigating published data-
sets generated in Dnmt-TKO and Dnmt3a/3b-DKO cells (King et al,
2016), we indeed observe that the CpG island promoters associated
with enriched DNMT3A1 binding display the strongest reduction in
H3K27me3 (Fig EV3A–C). And, as previously reported, by re-
expressing DNMT3A1 in Dnmt3a/3b-DKO cells, H3K27me3 distribu-
tion at these promoters is more effectively restored than by
DNMT3A2 or DNMT3B (King et al, 2016) (Fig EV3B and C). In
addition to the H3K27me3 dynamics, we further detect increased
DNaseI hypersensitivity and H3K27 acetylation in the absence of
DNA methylation in Dnmt-TKO cells at the same DNMT3A1-bound
and unmethylated CpG island promoters (Fig EV3D and E), coincid-
ing with frequent deregulation of the associated genes (Fig 6E).
Discussion
The de novo DNA methyltransferases DNMT3A and DNMT3B play
an important role in mediating site-specific DNA methylation and
are required to counteract active and passive removal of DNA
methylation (Jackson et al, 2004; Goll & Bestor, 2005; Baubec et al,
2015; Ambrosi et al, 2017). However, the individual or overlapping
roles of these enzymes in DNA methylation regulation are still not
fully understood. In part, this is due to the presence of various
isoforms and their differential expression, which inherently compli-
cates their analysis. In this study, we have identified the preferential
localization and activity of DNMT3A to H3K27me3-positive CpG
islands in ES and neuronal progenitor cells. DNMT3A binding does
not completely overlap with the H3K27me3 signal over the CpG
island, but is restricted to its shores—the methylated regions outside
of the island (Irizarry et al, 2009). This localization is in line with
repulsion of the de novo methyltransferases by H3K4me3 and deple-
tion of DNA methylation from the center of CpG islands (Otani et al,
2009), as well as with the reported role of the Polycomb-associated
protein KDM2B in protecting bivalent islands from DNA methylation
(Boulard et al, 2015). Importantly, this binding is mainly observed
for the larger isoform DNMT3A1, whereas the shorter version,
DNMT3A2, displays a more global binding and activity throughout
the genome.
We show that DNMT3A1 dynamically localizes to H3K27me3
during cellular differentiation, suggesting a recruitment mechanism
that is associated with H3K27me3 deposition. If and to what extent
H3K27me3 is directly involved in the recruitment of DNMT3A1
remains to be understood. Previous studies have reported interac-
tions between PRC2 complex members and DNMTs (Vire´ et al,
2005; Neri et al, 2013), and we observe similar interactions in our
own study. However, deletions of key PRC1 or PRC2 components
did not lead to changes in DNA methylation (Hagarman et al, 2013;
Boulard et al, 2015) and we do not detect differential interactions of
the DNMT3A isoforms with PRC2 component members, arguing
against a role of PRC members in recruiting DNMT3A1 through
protein–protein interactions. This suggests that the observed local-
ization could also be facilitated by unknown chromatin or DNA
features coinciding with Polycomb-regulated elements. Alterna-
tively, repulsion of DNMT3A1 could be more efficient around non-
bivalent CpG islands, either through increased presence of
H3K4me3 or through transcriptional activity. By engineering a
chimeric DNMT3A protein that contains the N-terminal part of
DNMT3B, we show that the preferential localization of DNMT3A1
to H3K27me3 is reduced, suggesting a requirement of the DNMT3A1
N-terminal part in specifying this localization, in line with previous
studies reporting DNA binding activity of this domain in vitro (Sue-
take et al, 2011). Nevertheless, this N-terminal domain replacement
does not increase the affinity of DNMT3A to H3K36me3, and we do
not observe any H3K36me3-dependent localization for both
DNMT3A isoforms in vivo—despite the presence of a PWWP domain
that binds H3K36me3 in vitro (Dhayalan et al, 2010). Further stud-
ies should bring insight into the mechanisms that lead to paralog-
and isoform-specific genomic targeting preferences of the de novo
DNA methyltransferases to H3K27me3 and H3K36me3 sites.
We further observe that DNMT3A1 localization to the shores of
Polycomb-regulated CpG islands coincides with elevated 5-hmC
deposition. Local enrichment of 5-hmC is indicative of an enhanced
turnover of methylated cytosines by the activities of TET and DNMT
enzymes at regulatory elements (Wu et al, 2011a; Pastor et al,
2011; Williams et al, 2011; Kohli & Zhang, 2013; Feldmann et al,
2013; Neri et al, 2015). Here, we report that the production of
5-hmC at H3K27me3-positive CpG islands is a consequence of
DNMT3A1 recruitment to the CpG island shores. Loss of DNMT3A
results in reduction in 5-hmC and subsequently erosion of methy-
lated cytosines around CpG islands, establishing DNMT3A as a regu-
lator of DNA methylation around these sites. This activity is in line
with previous observations made in hematopoietic stem cells (HSC),
where loss of DNMT3A resulted in expansion of large UMR, termed
“canyons” (Jeong et al, 2014)—highlighting that the delicate
balance between DNMT3A and TET activities is required to shape
the methylome in multiple tissues and cell types. By expressing indi-
vidual DNMT3A isoforms in Dnmt-TKO cells lacking DNA methyla-
tion and 5-hmC, we furthermore confirm that recruitment of the
DNMT3A1 isoform is sufficient for preferential re-setting of DNA
methylation at Polycomb CpG island shores. This enhanced de novo
methylation activity around Polycomb CpG islands is, however, not
observed for DNMT3A2, which acts as a global methylator—further
suggesting a specialization of the DNMT3A1 isoform. Moreover, re-
setting of DNA methylation by DNMT3A1 results in 5-hmC accumu-
lation, substantiating that recruitment of DNMT3A1 is required for
DNA methylation homeostasis at CpG island shores (Fig 6F).
It is well established that DNA methylation plays an important
role in restricting H3K27me3 to unmethylated CpG islands. This is
evident from preferential localization of H3K27me3 to endogenous
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and ectopic unmethylated CpG-rich regions (Tanay et al, 2007;
Mikkelsen et al, 2007; Mohn et al, 2008; Mendenhall et al, 2010;
Jermann et al, 2014; Wachter et al, 2014), the identification of PRC
complex members that preferentially bind unmethylated CpGs and
GC-rich sequences (Farcas et al, 2012; Wu et al, 2013; Li et al,
2017), and numerous studies that reported spreading of H3K27me3
in the absence of DNA methylation (Lynch et al, 2011; Brinkman
et al, 2012; Marks et al, 2012; Reddington et al, 2013; Jermann
et al, 2014; King et al, 2016). We suggest that the balance between
DNMT3A1 and TET activity is required to fine-tune the distribution
of methylated and unmethylated CpGs and for restricting Polycomb
domain boundaries to the promoters of developmentally regulated
genes. This is supported by the increased re-setting of H3K27me3 in
Dnmt3a/3b-DKO reconstituted with DNMT3A1 (King et al, 2016).
This supports the notion that DNA methylation can indirectly
influence gene activity through instructing H3K27me3 deposition
and that deregulation of this crosstalk could lead to disturbed execu-
tion of gene expression programs. Supporting evidence comes from
increased deregulation of Polycomb-target genes in the absence of
DNA methylation (Fouse et al, 2008; Wu et al, 2010; King et al,
2016), while in TET-knock-out ES cells, increased DNA methylation
at Polycomb CpG islands results in derepression of the associated
genes (Wu et al, 2011b; Lu et al, 2014; Kong et al, 2016). Further-
more, the crosstalk between DNA methylation and H3K27me3 is
frequently disturbed in cancers. Several Polycomb-regulated
promoters become hypermethylated during cancer progression,
potentially resulting in a more stable, long-term repression by DNA
methylation (Schlesinger et al, 2006; Widschwendter et al, 2006;
Gal-Yam et al, 2008). And in leukemias, loss of DNMT3A activity is
associated with hypomethylation around CpG islands and deregula-
tion of Hox genes (Yan et al, 2011; Qu et al, 2014; Spencer et al,
2017). Our study identifies an isoform-specific function of DNMT3A
at Polycomb sites that offer novel insights into the mechanisms
underlying these epigenetic dynamics and provide potential targets
for future therapies.
Materials and Methods
Cell culture and neuronal differentiation
Mouse embryonic stem cells were cultured on 0.2% gelatine-coated
dishes in DMEM (Invitrogen) supplemented with 15% fetal calf
serum (Invitrogen), 1× non-essential amino acids (Invitrogen),
1 mM L-glutamine, leukemia inhibitory factor, and 0.001%
b-mercaptoethanol. Differentiation was performed as previously
described (Bibel et al, 2007). 4 × 106 mES cells were cultivated in
non-adherent bacterial dishes for 4 days for the formation of cellular
aggregates in DMEM supplemented with 10% fetal calf serum (Invit-
rogen), 1× non-essential amino acids (Invitrogen), 1 mM L-gluta-
mine, and 0.001% b-mercaptoethanol. Cellular aggregates were
further cultivated in the same medium supplemented with 5 lM
retinoic acid for additional 4 days.
Cell line generation
cDNA encoding DNMT3A1 was amplified from ESC mRNA extracts
and cloned into pL1-CAGGS-bio-MCS-polyA-1L or pCAGGS-bio-
MCS-IRES-BlasticidinR-polyA. Detailed cloning strategies and
constructs are available upon request. Biotin-tagged DNMT3A1 cell
lines were obtained by recombinase-mediated cassette exchange
(RMCE) or by random integration as previously described (Baubec
et al, 2013). Dnmt3a-KO cell lines were generated by transfecting
px330 (Cong et al, 2013) with two guides targeting exon seven.
Guide 1: CTCATACTCAGGCTCATCGT and guide 2: GTCGGAGAAG
CAGGGTCCGT.
Nuclear extract preparation for targeted proteomics and biotin
co-immunoprecipitation MS
Cell pellets were resuspended gently in 4–5× pellet volume (PV) of
nuclear extract buffer 1 (NEB1) with 10 mM HEPES pH 7.5, 10 mM
KCl, 1 mM EDTA, 1.5 mM MgCl2, 1 mM dithiothreitol, and 1×
protease inhibitor cocktail and incubated for 10 min on ice. Cells
were centrifuged at 2,000 × g at 4°C for 10 min. Supernatant was
removed and cell pellets were resuspended in 2× PV of NEB1 and
homogenized. Suspension was centrifuged at 2,000 × g at 4°C for
10 min twice and the pellet was resuspended in 1× PV and incubated
with 300 U Benzonase per 1 ml total volume for 3 h at 4°C rotating,
followed by centrifugation at 2,000 × g at 4°C for 10 min. The pellet
was resuspended in 1× PV of NEB2 (20 mM HEPES pH 7.5, 20%
glycerol, 0.2 mM EDTA, 1.5 mM MgCl2, 1 mM dithiothreitol, 1×
protease inhibitor cocktail, and 450 mM NaCl) and homogenized.
Nuclear proteins were extracted for 1 h at 4°C, and protein concen-
trations were measured by Qubit protein assays (TS).
For biotin co-immunoprecipitation, equal amounts of nuclear
extracts (NE) were diluted with 2× the volume of 20 mM HEPES pH
7.5, 20% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, and
1× protease inhibitor cocktail and NP-40 was added to a final
concentration of 0.3%. NE were incubated with 40 ll Streptavidin-
M280 (11206D) beads overnight, rotating at 4°C. Beads were sepa-
rated from the NE on a magnetic rack and washed once for 10 min
rotating overhead at 4°C with 20 mM HEPES pH 7.5, 20% glycerol,
1.5 mM MgCl2, 0.2 mM EDTA, 150 mM NaCl, 0.3% NP-40, 1 mM
DTT, and 1× protease inhibitor cocktail. Beads were washed again
with the same buffer without NP-40, and 10 min with 50 mM Tris
pH 8.5, 1 mM EGTA, 75 mM KCl, each 10 min rotating overhead at
4°C. Proteins were eluted by adding 200 ll of 8 M urea (GEPURE00-
66) in 100 mM Tris–HCl pH 8.2 and DTT at a final concentration of
0.1 M by shaking for 30 min at room temperature in a thermomixer.
Separated supernatant was processed immediately for FASP digest
(Wisniewski et al, 2009) using the whole eluate. Samples were then
desalted with C18 ZipTips (ZTC18S960) according to the user
manual.
Mass spectrometry detection of DNMT3A-interacting proteins
Dissolved samples were injected by a Waters M-class UPLC system
(Waters AG) and separated on a C18 reverse-phase column (HSS T3
1.8 lm, 75 lm × 250 mm, Waters AG). The column was equili-
brated with 99% solvent A (0.1% formic acid (FA) in water) and
2% solvent B (0.1% FA in ACN). Peptides were eluted using
the following gradient: 2–25% B in 50 min; 25–35% B in 10 min;
35–98% B in 5 min. The flow rate was constant, 0.3 ll/min. High
accuracy mass spectra were acquired with a Q-Exactive HF
mass spectrometer (Thermo Scientific) that was operated in
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data-dependent acquisition mode. A survey scan was followed by
up to 12 MS2 scans. The survey scan was recorded using quadru-
pole transmission in the mass range of 350–1,500 m/z with an AGC
target of 3E6, a resolution of 120,000 at 200 m/z, and a maximum
injection time of 50 ms. All fragment mass spectra were recorded
with a resolution of 30,000 at 200 m/z, an AGC target value of 1E5,
and a maximum injection time of 50 ms. The normalized collision
energy was set to 28%. Protein identification and reporting from
MS-raw data was performed with Mascot and Scaffold, respectively.
Only proteins with a minimum of four unique spectral counts were
utilized for the final dataset and contaminants were manually
removed.
Chromatin immunoprecipitation (ChIP)
For cross-linking and chromatin extraction, 10–20 × 106 cells were
fixed for 8 min with 1% formaldehyde at room temperature
followed by the addition of glycine (final concentration 0.12 M) and
incubation for 10 min on ice. Cells were harvested and incubated
for 10 min in 5 ml 10 mM EDTA, 10 mM TRIS, 0.5 mM EGTA on
ice, followed by centrifugation at 680 × g for 5 min. Cells were
resuspended in 5 ml buffer containing 0.25% Triton X-100, 1 mM
EDTA, 10 mM TRIS, 0.5 mM EGTA, and 200 mM NaCl and incu-
bated for 10 min on ice followed by centrifugation at 680 × g for
5 min. Final cell lysis was performed with 50 mM HEPES, 1 mM
EDTA, 1% Triton X-100, 0.1% deoxycholate, 0.2% SDS, and
300 mM NaCl (medium salt buffer) in a pellet size-dependent
volume (ranging from 0.9 to 1.2 ml) for 1 to 2 h on ice. Cross-linked
chromatin was subjected to sonication in a Bioruptor Pico instru-
ment (Diagenode) according to the manufacturer’s instructions.
Sonicated chromatin was centrifuged at 12,000 × g for 10 min at
4°C and supernatant was used for further steps. Streptavidin-M280
magnetic beads were blocked for 1 h with 1% cold fish skin gelatin
(Sigma Aldrich) and 100 ng tRNA (Sigma Aldrich) supplemented
with protease inhibitor cocktail mix (Roche) and washed twice with
buffer 3 with 0.1% SDS and 150 mM NaCl. 150–250 lg chromatin
solution was diluted to 0.1% SDS and 150 mM NaCl. Chromatin
was then incubated with 30 ll pre-blocked streptavidin-M280
magnetic beads overnight at 4°C. Beads were washed under rotation
for 8 min for each wash step and placed on a magnetic rack for
2 min for exchange of buffers first with two rounds of 2% SDS, high
salt buffer (as medium salt buffer, but 0.1% SDS and 500 mM
NaCl), DOC buffer (250 mM LiCl, 0.5% NP-40, 0.5% deoxycholate,
1 mM EDTA, 10 mM TRIS), and two rounds of Tris/EDTA buffer.
Beads were treated with RNaseA (60 lg, Roche) for 30 min at 37°C
in 1% SDS, 0.1 M NaHCO3, and subsequently proteinase K (60 lg,
Roche) for 3 h at 55°C in 1% SDS, 0.1 M NaHCO3, 10 mM EDTA,
20 mM TRIS, followed by de-cross-linking overnight at 65°C.
DNA was purified with phenol–chloroform extraction and ethanol
precipitation.
5-hydroxy-MeDIP-seq libraries
Genomic DNA was sonicated to 150–300 bp and RNaseA treated
prior to end-repair and A-tailing using the NEB Ultra library kit and
protocol (E7370). NEB adapters were ligated to the genomic DNA
following the NEB Ultra protocol, and DNA was cleaned up using
Ampure XP beads (Beckman Coulter). Following cleanup, 5 lg
adapter-ligated DNA was taken up in 500 ll TRIS/EDTA and dena-
tured for 10 min in a boiling water bath. 5-hmC-containing DNA
was enriched using the Active Motif 5-hmC antibody (39769) as
described in Feldmann et al (2013). Enriched DNA was amplified by
PCR with 15 cycles prior to sequencing.
ChIP-seq library preparation and high-throughput sequencing
For ChIP-seq, libraries were prepared using the NEB-next ChIP-seq
library Kit (E62402) following the standard protocols. Four to five
samples with different index barcodes were combined at equal
molar ratios and sequenced as pools. Sequencing of library pools
was performed on Illumina HiSeq 2500 machines according to Illu-
mina standards, with 75- to 150-bp single-end sequencing. Library
demultiplexing was performed following Illumina standards.
Reduced-representation bisulfite library preparation
Prior to library preparation, unmethylated lambda phage DNA and
SssI-methylated T7 DNA were spiked in to genomic DNA samples to
control bisulfite conversion rates. For RRBS, 20 lg of DNA was
digested for 18 h by MspI and separated on 2% agarose gels.
Digested DNA was excised at 150–250 and 250–350 bp. Digested
DNA samples were end-repaired and A-tailed using the NEB Ultra
Illumina library preparation kit (E7370). DNA fragments were
ligated to methylated adapters (NEB E7535) following the NEB Ultra
protocol. After adapter removal using Ampure XP beads (Beckman
Coulter), DNA was converted using the Qiagen Epitect bisulfite
conversion kit following the FFT sample protocol. After conversion,
library PCR amplification was performed with 10 cycles following
NEB Ultra kit protocol and cleaned up using Ampure XP beads. Two
libraries were generated each for 150- to 250-bp and 250- to 350-bp
inserts.
Whole-genome bisulfite library preparation
Similar to RRBS, unmethylated lambda phage DNA and SssI-
methylated T7 DNA were spiked in to the genomic DNA samples.
For WGBS, 20 lg of DNA was sonicated to ca 500 bp using a
Bioruptor Pico. Sonicated DNA were end-repaired and A-tailed
using the NEB Ultra Illumina library preparation kit (E7370). DNA
fragments were ligated to methylated adapters (NEB E7535)
following the NEB Ultra protocol. After adapter removal using
Ampure XP beads (Beckman Coulter), DNA was converted using
the Qiagen Epitect bisulfite conversion kit following the FFT
sample protocol. After conversion, library PCR amplification was
performed with 10 cycles following NEB Ultra kit protocol and
cleaned up using Ampure XP beads.
ChIP-seq, 5-hMeDIP, and bisulfite sequencing reads processing
Samples were filtered for low-quality reads and adaptor sequences
and mapped to the mouse genome (version mm9) using the
BOWTIE algorithm allowing for two mismatches and only unique
mappers were used. Identical reads from PCR duplicates were fil-
tered out. For whole-genome bisulfite sequencing analysis, reads
were partitioned into 40 bp and pooled for subsequent alignment.
Bisulfite alignments were performed using QuasR in R (Gaidatzis
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et al, 2015) with standard parameters for single-read bisulfite align-
ments. Methylation calls and read coverage per CpG were extracted
and only CpGs covered more than ten times were used for subse-
quent analysis. CpGs overlapping with SNPs were removed. Bisul-
fite conversion quality was confirmed by spiked-in controls of
methylated T7 DNA and unmethylated lambda DNA.
Genomic coordinates
Genomic annotations are based on the Mus musculus version
NCBI37/mm9 from July 2007. Genome segmentations based on
DNA methylation corresponding to FMR, LMR, and UMR were
obtained from Stadler et al (2011). For average density plots in
Fig 1, UMRs and LMRs were filtered based on distance (> 6 kb)
and FMRs larger than 12 kb were used to avoid overlaps between
these features. Furthermore, FMRs were binned into three equal
bins based on DNA methylation density. For identification and
visualization of promoter UMRs, only UMRs were used that
overlapped with gene promoters and these UMRs were oriented
according to the gene orientation. UMR borders were defined at the
end and start of the preceding and following FMR, respectively.
CpG island annotation is based on the CpG cluster algorithm
(Hackenberg et al, 2006). We removed all CpG islands that were
shorter than 200 bp and retained all CpG islands overlapping with
gene promoters. Promoter CpG islands with m-CpG average below
20% were assigned as unmethylated and further binned as bivalent
based on H3K27me3 and H3K4me3 enrichments (Appendix Fig
S4C). RefSeq genes and promoters were obtained from UCSC
(genome.ucsc.edu), and only non-overlapping genes were used for
further analysis.
DNA methylation analysis
DNA methylation percentage, CpG and m-CpG densities per
analyzed regions were calculated as described previously (Stadler
et al, 2011; Baubec et al, 2013). Densities were calculated as the
sum of SNP-filtered CpGs per analyses region and normalized to
100 bp. Global re-methylation was calculated as percent of methy-
lated cytosines within different sequence contexts for the entire
library. For WGBS, only CpGs covered more than ten times were
considered; for RRBS, only CpGs covered more than 20 times.
Genome-wide enrichments and identification of
DNMT-enriched regions
The mouse genome was partitioned into 1-kb-sized tiling windows.
Genomic regions overlapping with satellite repeats (Repeatmasker),
ENCODE black-listed (ENCODE Project Consortium, 2012), and low
mappability scores [(Derrien et al, 2012), below 0.5] were removed
in order to reduce false positives arising from differences between
mouse strains, annotation errors, and repetitiveness. Furthermore,
DNA methylation scores in ES and NP cells windows with insuffi-
cient coverage in whole-genome bisulfite sequencing (> 50% of all
CpGs covered at least 10 times) were removed. ChIP enrichments
were calculated as log2-fold changes over input chromatin after
library size normalization and using a constant of eight pseudo-
counts to reduce sampling noise. ChIP enrichments were subse-
quently used for cross-correlation analysis, enrichment calculations
at DNMT-bound sites, or dynamic analysis in ES and NP cells. We
utilized DEseq2 (Love et al, 2014) to identify regions exclusively
bound by DNMT3 proteins. Prior to identifying these regions, we
removed all genomic windows that did not contain sequencing read
counts in any of the foreground or background samples and identi-
fied bound regions as FC > 1 and adjusted P-value < 0.002.
Enriched regions from all three DNMT proteins were intersected and
only regions exclusively bound by the individual DNMTs were
further used to calculate distributions of genomic and epigenomic
features, calculate DNA methylation, or generate meta-profiles using
genomation in R (Akalin et al, 2014).
Data access
All datasets produced in this study (Appendix Table S1) have been
deposited to the NCBI Gene Expression Omnibus under the acces-
sion: GSE96529. Additional datasets from other publications are
listed in Appendix Table S2.
Expanded View for this article is available online.
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